Virginia Regulatory Town Hall
Department of Health Professions
Board of Medicine
Regulations Governing the Practice of Physician Assistants [18 VAC 85 ‑ 50]
Previous Comment     Next Comment     Back to List of Comments
6/28/23  9:30 pm
Commenter: Rebecca Agbayani, PA-C


I fully support the removal of requirements to include a physician's name, NPI, and DEA information on Schedule II-V prescriptions. 

The collaborating physician is rarely directly involved in the patient's care on a day-to-day basis, and requiring their information on these prescriptions is an unnecessary burden in their role as collaborator.  Additionally, as PA's we have our own license, NPI, and DEA, so are fully able and expected to carry the burden of responsibility and liability that comes with prescribing medications.  This unnecessary paperwork step increases the amount of time I spend in front of my computer or on the phone rather than with my patients, and can result in delays of timely filling of prescriptions at the pharmacy. 

This is an easy win to remove some bureaucratic red tape and make everyone's jobs a little easier.

CommentID: 217520